Abivax CEO Says Big Pharma Can’t Ignore Its Experimental Drug - Bloomberg.com

Abivax SA’s shares pared gains after France’s finance ministry said it has not been contacted by Eli Lilly & Co. about a possible bid for the French biotech.

You will be redirected in 10 seconds.